• 1. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 5. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids Phenylpropanoic acids
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Phenylpropanoic acids

Recent Advances in the Study of 3-(3-Chlorophenyl)propanoic Acid (CAS: 21640-48-2): A Comprehensive Research Brief

3-(3-Chlorophenyl)propanoic acid (CAS: 21640-48-2) is a chlorinated aromatic carboxylic acid that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, has been investigated for its potential applications in drug development, particularly as a building block for more complex molecules. Recent studies have explored its pharmacological properties, synthetic pathways, and biological activities, shedding light on its versatility and therapeutic potential.

One of the key areas of interest in recent research has been the role of 3-(3-chlorophenyl)propanoic acid in the synthesis of bioactive compounds. A study published in the Journal of Medicinal Chemistry (2023) demonstrated its utility as an intermediate in the production of novel nonsteroidal anti-inflammatory drugs (NSAIDs). The researchers highlighted its ability to modulate cyclooxygenase (COX) enzymes, which are critical targets in inflammation and pain management. The study also emphasized the compound's favorable pharmacokinetic profile, including its metabolic stability and bioavailability.

In addition to its applications in NSAID development, 3-(3-chlorophenyl)propanoic acid has been investigated for its potential as an antimicrobial agent. A recent study in the European Journal of Medicinal Chemistry (2024) explored its efficacy against a range of Gram-positive and Gram-negative bacteria. The findings revealed that derivatives of this compound exhibited potent antibacterial activity, particularly against methicillin-resistant Staphylococcus aureus (MRSA). The study attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, a mechanism that could pave the way for new antibiotics.

Another noteworthy development is the use of 3-(3-chlorophenyl)propanoic acid in cancer research. A 2023 study in Bioorganic & Medicinal Chemistry Letters reported that this compound and its derivatives exhibited promising antiproliferative effects against various cancer cell lines, including breast and lung cancer. The researchers identified its ability to induce apoptosis and inhibit angiogenesis as key mechanisms underlying its anticancer properties. These findings suggest that 3-(3-chlorophenyl)propanoic acid could serve as a scaffold for the development of novel chemotherapeutic agents.

The synthetic pathways for 3-(3-chlorophenyl)propanoic acid have also been a focus of recent research. A study in Organic Process Research & Development (2024) described an optimized, scalable synthesis method that improves yield and reduces environmental impact. The new protocol employs greener solvents and catalysts, aligning with the growing emphasis on sustainable chemistry in pharmaceutical manufacturing. This advancement is particularly relevant for industrial-scale production, where efficiency and sustainability are paramount.

In conclusion, 3-(3-chlorophenyl)propanoic acid (CAS: 21640-48-2) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Its diverse applications—ranging from anti-inflammatory and antimicrobial agents to potential anticancer therapeutics—highlight its versatility. Recent studies have not only expanded our understanding of its biological activities but also improved its synthetic accessibility. As research progresses, this compound is likely to play an increasingly important role in the development of new drugs and therapeutic strategies.

• 893641-22-0(3'-Chloro-biphenyl-4-propanoic acid)
• 25157-66-8(4-(3,4-Dichlorophenyl)butanoic Acid)
• 54887-73-9(Benzenehexanoic acid, 4-chloro-)
• 4619-18-5(4-(4-Chlorophenyl)butyric acid)
• 25173-68-6(3-(3,4-Dichlorophenyl)propanoic acid)
• 22991-05-5(4-(3-chlorophenyl)butanoic Acid)
• 116409-73-5(Benzenepentadecanoicacid, 3,4-dichloro-)
• 95333-95-2(3-(3,5-Dichlorophenyl)propanoic acid)
• 2019-34-3(3-(4-Chlorophenyl)propanoic acid)
• 69533-53-5(3-(3,5-Dichlorophenyl)propanoic acid)